Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0SB5K
|
||||
| Former ID |
DCL000636
|
||||
| Drug Name |
SAR164877
|
||||
| Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Phase 2/3 | [525196] | ||
| Therapeutic Class |
Analgesics
|
||||
| Company |
Sanofi-Aventis
|
||||
| Target and Pathway | |||||
| Target(s) | Beta-nerve growth factor | Target Info | Modulator | ||
| Reactome | Frs2-mediated activation | ||||
| ARMS-mediated activation | |||||
| NRAGE signals death through JNK | |||||
| p75NTR negatively regulates cell cycle via SC1 | |||||
| PI3K/AKT activation | |||||
| NADE modulates death signalling | |||||
| NRIF signals cell death from the nucleus | |||||
| p75NTR recruits signalling complexes | |||||
| NF-kB is activated and signals survival | |||||
| Axonal growth stimulation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.